In the Media

BioSpace with Tristan Manalac, 5 Biotechs Taking the Pipeline-in-a-Product Approach to Drug Development

August 20, 2025

The platform strategy of using one molecule to target an underlying biological pathway to address many different diseases can be a goldmine for smaller companies... full article

Informa’s BioXconomy with Millie Hoe

August 15, 2025

The company will trial its compound zelpultide alfa in over 300 pre-term neonates with bronchopulmonary dysplasia... full article

Pharma Focus Europe Editorial Team

August 13, 2025

Airway Therapeutics, Inc., a clinical-stage biopharmaceutical company developing biologic therapies for respiratory, inflammatory, and infectious diseases, has received approval from the European Medicines Agency’s (EMA) Paediatric Committee (PDCO) for its Paediatric Investigation Plan (PIP) for zelpultide alfa... full article

MedPath Editorial Team

August 12, 2025

Airway Therapeutics announced that the European Medicines Agency (EMA) Pediatric Committee (PDCO) has approved its Pediatric Investigation Plan (PIP) for zelpultide alfa... full article